A New Pharmacokinetic Approach for a Better Understanding of the Relationship Between the Terminal Half-Life of Drug and Its Physiologically Based Pharmacokinetic Parameters
Copyright © 2020 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved..
The terminal half-life (T1/2) of a biphasic declining plasma concentration-time profile of a drug after intravenous administration is proportional to a ratio between its systemic clearance (CL) and volume of distribution at pseudo-distribution equilibrium (Vdβ). Due to lack of understanding of Vdβ, simply known as a proportionality constant between the amount of drug in the body and its plasma concentration during the terminal phase, the effects of various physiologically based pharmacokinetic parameters of drug on T1/2 could not have been evaluated. The objective of the current study is to offer a new theoretical ground, using the Taylor series expansion, for a better understanding of relationships among T1/2, CL, distributional clearance (CLd) and volumes of distribution in the tissue compartment (VT) and at steady state (Vdss) of drug in a 2-compartment model after intravenous administration. Similar CL and Vdss yet different T1/2 of drugs found in pharmacokinetic studies might be due to differences in CLd and VT of those drugs. In conclusion, the new equation (T1/2 ≈ 0.693 (Vdss/CL + VT/CLd) explicitly shows how the physiologically based pharmacokinetic parameters of drug could affect its T1/2 after intravenous administration.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:109 |
---|---|
Enthalten in: |
Journal of pharmaceutical sciences - 109(2020), 3 vom: 15. März, Seite 1421-1423 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kwon, Younggil [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 17.06.2021 Date Revised 17.06.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.xphs.2019.12.010 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM304642053 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM304642053 | ||
003 | DE-627 | ||
005 | 20231225115424.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.xphs.2019.12.010 |2 doi | |
028 | 5 | 2 | |a pubmed24n1015.xml |
035 | |a (DE-627)NLM304642053 | ||
035 | |a (NLM)31863732 | ||
035 | |a (PII)S0022-3549(19)30816-0 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kwon, Younggil |e verfasserin |4 aut | |
245 | 1 | 2 | |a A New Pharmacokinetic Approach for a Better Understanding of the Relationship Between the Terminal Half-Life of Drug and Its Physiologically Based Pharmacokinetic Parameters |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 17.06.2021 | ||
500 | |a Date Revised 17.06.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2020 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved. | ||
520 | |a The terminal half-life (T1/2) of a biphasic declining plasma concentration-time profile of a drug after intravenous administration is proportional to a ratio between its systemic clearance (CL) and volume of distribution at pseudo-distribution equilibrium (Vdβ). Due to lack of understanding of Vdβ, simply known as a proportionality constant between the amount of drug in the body and its plasma concentration during the terminal phase, the effects of various physiologically based pharmacokinetic parameters of drug on T1/2 could not have been evaluated. The objective of the current study is to offer a new theoretical ground, using the Taylor series expansion, for a better understanding of relationships among T1/2, CL, distributional clearance (CLd) and volumes of distribution in the tissue compartment (VT) and at steady state (Vdss) of drug in a 2-compartment model after intravenous administration. Similar CL and Vdss yet different T1/2 of drugs found in pharmacokinetic studies might be due to differences in CLd and VT of those drugs. In conclusion, the new equation (T1/2 ≈ 0.693 (Vdss/CL + VT/CLd) explicitly shows how the physiologically based pharmacokinetic parameters of drug could affect its T1/2 after intravenous administration | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Taylor series expansion | |
650 | 4 | |a half-life | |
650 | 4 | |a pharmacokinetics | |
650 | 4 | |a physiologically based pharmacokinetic parameters | |
650 | 4 | |a pseudo-distribution equilibrium | |
650 | 4 | |a terminal phase | |
650 | 4 | |a volume of distribution | |
650 | 7 | |a Pharmaceutical Preparations |2 NLM | |
773 | 0 | 8 | |i Enthalten in |t Journal of pharmaceutical sciences |d 1961 |g 109(2020), 3 vom: 15. März, Seite 1421-1423 |w (DE-627)NLM000006394 |x 1520-6017 |7 nnns |
773 | 1 | 8 | |g volume:109 |g year:2020 |g number:3 |g day:15 |g month:03 |g pages:1421-1423 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.xphs.2019.12.010 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 109 |j 2020 |e 3 |b 15 |c 03 |h 1421-1423 |